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ABSTRACT
￿
We explored the retraction or contraction of platelet-fibrin clots under isometric
conditions . In the presence of micromolar calcium clots of normal platelet-rich plasma
developed tension at an initial rate of 0.1 to 0.2 g/min per cm2 (initial cross-sectional area) .
Electron microscopy of clots fixed after attaining a force of 1 .6 g/cm 2 revealed platelets with
elongated bodies and pseudopods in close apposition to fibrin strands which were oriented in
cablelike fashion in the direction of tension . The development of tension could not be
explained simply on the basis of platelet-platelet association and interaction alone . First, factor
XIII-dependent cross-linking of fibrin fibers was critical to normal isometric contraction .
Second, tension decreased linearly, rather than exponentially, when the platelet count in the
platelet-fibrin clot was decreased, suggesting that platelets must be interacting with another
component (i .e . fibrin) . Thrombasthenic platelets, deficient in fibrinogen receptors, failed to
develop tension or to align fibrin strands or pseudopods in the clot. Platelet-fibrin clots treated
with vincristine to disassemble microtubules or cytochalasin B to disrupt microfilaments failed
to develop tension and relaxed if these agents were added after tension had developed .
Relaxation under these conditions, however, was not associated with loss of orientation of
fibrin strands . Our findings suggest that platelet-fibrin interaction in clots under isometric
conditions leads to orientation of fibrin strands and platelets in the direction of force generation .
Tension develops as platelets simultaneously attach to and spread along fibrin strands, and
contract . The contraction draws some fibrin into platelet-fibrin clumps and aligns other strands
in the long axis of tension . The achievement and maintenance of maximum tension appears to
depend on the development of platelet-fibrin attachments and extension of platelet bodies
and long pseudopods containing bundles of microfilaments and microtubules along the
oriented fibrin fibers .
The phenomenon of clot retraction has been recognized for
more than two hundred years (20) . Physiologically, clot retrac-
tion may enhance clot lysis and facilitate recanalization of
blood vessels (6) . Mechanistically, clot contraction remains
poorly understood, though in platelet-rich plasma it has been
clearly shown to result from the interaction of a static, non-
motile fibrin mesh and dynamic, actively motile blood platelets
(5, 12, 13, 29, 39) . Concepts concerning interaction of these two
components can be classed into three general proposals . The
first suggests that platelets reach out with their pseudopods to
combine with and attach to strands of fibrin . Pseudopods then
contract, pulling the fibrin mesh toward the platelets . Accord-
ing to one variation of this concept, the center of the platelet
may be an anchoring point for pulling in the fibers (35, 43) .
Another modification proposes that contraction is related to
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platelet-platelet interaction, and occurs between adhesion sites
formed by cytoplasmic protrusions from adjacent cells (12) . In
the second general concept, pseudopodia are envisaged as
exercising sweeping movements that gather in and compress
fibrin fibers (1, 8) . A third proposal, called the zipper model
(9), suggests that platelet-platelet stickiness is critical in clot
retraction. In this model, platelets are envisaged as undergoing
contraction after having extended long pseudopods which join
adjacent platelets. The surfaces of these adjacent platelets are
then slowly zippered together compressing the fibrin fibers
inside .
Significant advances in the undçrstanding of muscle physi-
ology developed as a result of evaluating contractile events in
muscle strips fixed under constant tension . We have applied
this principle to the study of clot retraction and have investi-
775gated the process of contraction with the ends of the clot tied
and maintained a fixed distance apart. Under these conditions
isometric contraction of the clot generates tension (8) . The
effect of factor XIIIa-catalyzed cross-linking of fibrin on clot
retraction was studied . Factor XIIIa, the last enzyme in the
coagulation cascade is the thrombin- and Ca'-activated form
of the zymogen, termed factor XIII, which is present in plasma
and in the platelet cytosol . It is a highly specific transglutami-
nase of the endo-y-glutamine:e-lysine transferase type and it
catalyzes the formation ofthe e-(y-glutamyl)-lysine linkages in
fibrin and various cytoskeletal proteins (10, 14, 26) . Niewia-
rowski et al . (32) determined that clot retraction induced by
platelets is prevented with fully cross-linked fibrin fibers . We
investigated the role of fibrin cross-linking on the development
of isometric tension, as well as on the ultrastructural features
of platelet-rich fibrin clots . The results of these studies provide
evidence to distinguish among current models ofclot retraction
and to propose a new model for its mechanism .
MATERIALS AND METHODS
Platelet Suspensions
Venous blood was collected from the antecubital vein of normal donors or
patients after obtaining informed consent and anticoagulated using I vol of citric
acid-citrate-glucose (ACD) for 9 vol of blood . Platelet-rich plasma andwashed
platelets were prepared and maintained at room temperature and were used
within 3 h of blood collection. Platelet-rich plasma was obtained after centrifu-
gation at 125 g for 10 min . When washed platelets were required, platelet-rich
plasma was adjusted to pH 6.5 with 0.15M citricacid, and plateletswere washed
three times according to the method ofJenkins et al. (22) using 0.154M sodium
chloride, 0.0154M Tris-HCI, 5.5 mM glucose, 6.6 mM EDTA, pH 7.35 (to be
called Jenkins' buffer) . Platelets were sedimented by centrifugation at 1,000g for
15 min. When necessary, the platelet suspension was centrifuged at room tem-
perature at 120g for 5 min to sediment contaminating erythrocytes and leuko-
cytes. The final pellet, consisting only ofplatelets, waswashed in Jenkins' buffer
which did not contain EDTA, and suspended in the approxiate platelet-poor
plasma. Platelets were counted using a Coulter Counter (Thrombocounter C;
Coulter Electronics, Inc., Hialeah, FL).
Contraction Measurements
Isometric measurements were performed as described by Cohen and de Vries
(8) on thrombin-clotted platelet-rich plasma . Cylindrical clots were obtained by
pouring 1 mlofplatelet-rich plasma, immediatelyafter thrombin addition (Parke-
Davis, Division ofWarner-Lambert, Inc., Morris Plains,NJ; 1 U/ml), into glass
cylinders (7 x0.5 cm ID) plugged at one end with parafilm. After 9 min, the clot
cylinder was poured into a Petri dish containing Cat'-free Tyrode buffer (40) at
2°C to prevent clot shortening. The clot was then tied at oneend with a cotton
thread to a silver alloy wire holder and to the other end to a force displacement
transducer (Model FT 03, Grass Instrument Co ., Quincy,MA) linked to aModel
79D Polygraph System (Grass Instrument Co .) . The clot was immersed into an
isolated tissue bath (Metro Scientific, Farmingdale, NY) containing the afore-
mentioned Tyrode buffer maintained at 37°C. A preload of 82 mg was applied
to straighten the clot. Since the transducer developeda displacement rate of0.02
mm/g, isometric contraction was measured in the longitudinal direction. Con-
traction in the absence ofan external load was perforated using the floating clot
technique whereby the rate ofshortening ofa cylindrical clot freely suspended in
Tyrode solution at 37°C was measured. The final platelet concentration was4 to
5 x 105/Al, unless specified otherwise .
Electron Microscopy
Clots were fixed under tension using a modification ofpreviously described
methods for fixation of platelets (18, 42) . The Tyrode solution surrounding the
clot was drained and replaced by 20 ml of a solution containing 10 ml of the
original Tyrode solution and 10 ml of2% glutaraldehyde in White's saline (42).
After 5 min of 37°C, this solution was drained and immediately replaced by a
mixture of 10 ml of Tyrode and 10 ml of 6% glutaraldehyde in White's saline .
After 30 min at 37°C in this fixative solution the clot was removed and cut into
small fragments so that the initial orientation of the clot was preserved . The clot
fragments were fixed an additional 30 min at room temperature in 3% glutaral-
dehyde in White's saline . The fragments were then transferred to a solution of
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1% osmium tetroxide in a 15 mg/ml solution of potassium ferrocyanide in
distilled water (pH 7.4) for 90 min at 2°C. Afterosmium fixation, the samples
were dehydrated in a graded series of ethanol concentrations, then treated with
propylene oxide and embedded in Epon. Sections were cut with the sample
oriented either along the direction of tension (longitudinal section) or across the
direction of tension (cross-section). The sections were then stained using uranyl
acetate and lead citrateand viewed usingeither a Philips 301 electron microscope
ora Philips400 electron microscope witha goniometer stage . Sectionsfrom some
clots fixed at half-maximal or maximal tension were picked up on 200, rather
than 300mesh grids to facilitate identification of serial sections.
Patients
Freeze-dried plasma from three patients lacking factor XIII were kindly
suppliedby Dr. TadashiKamiya (Nagoya University School ofMedicine,Japan)
and Dr. Jeanne Stibbe (University of Rotterdam, The Netherlands) . The clots
obtained from these plasmas solubilized within 45 min in 5Murea and within 3
min in 1% monochloracetic acid .<1% factor XIII was detected by the antifactor
XIII inhibition test (3) and no evidence of factor XIII was detected with the
eledroimmunoassay (24) in the two plasmas provided by Dr. Kamiya.
The patient with Glanzmann's thrombasthenia is from a previously described
family, and his platelets have been well characterized and shown to be markedly
deficient in glycoproteins Ilb and III (17, 33) . The patient with storage pool
deficiencyhas been described previously (16) and has been shownto be markedly
deficient in dense bodies and their contents ofADPand serotonin . The patient
with the gray plateletsyndromehasbeen well characterized as havinga deficiency
ofalpha granules and their contents ofthrombin-sensitive protein, platelet factor
4, beta-thromboglobulin and fibrinogen (19) .
Preparation of Plasma Factor X111
Plasma factor XIII was prepared according to the method ofLoewy et al . (25)
as modified by Curtis and Lorand (11) .
Vincristine was obtained from Eli Lilly & Company (Indianapolis, IN) and
cytochalasins B and E from the Sigma Chemical Company (St . Louis, MO).
Stock solutions of 8 x IO-aMofthe cytochalasins were made in absolute ethanol .
RESULTS
Noncontracted Clots
Samples of platelet-rich plasma were allowed to clot under
conditions used to prepare clots for study in the absence of an
external load or in isometric conditions, but were fixed imme-
diately after clot formation . Ultrastructural evaluation revealed
platelets to be far apart, usually single but sometimes in small
clumps (Fig . 1) . Most of the platelets appeared degranulated
and showed signs of pseudopod formation . The pseudopods
were oriented randomly and few associations of platelets with
fibrin strands were seen. The orientation of the fibrin strands
was random throughout the clot .
Clots Contracted in the Absence of an External
Load
Clots allowed to contract in the absence of an external load
revealed the morphological features described by many pre-
vious investigators (5, 12, 43) (Fig . 2) . Platelets and fibrin were
gathered into large clumps and appeared relatively spherical in
thin sections . Fibrin tended to be concentrated toward the
center of the clumps while platelets were more prominent at
the periphery . Some of the peripherally oriented platelets or
pseudopods appeared swollen into spherical forms . Platelet
bodies, pseudopods, and fibrin strands were organized in a
purely random fashion in clots contracted in the absence of an
external load .
Clots Contracted Under Isometric Conditions
Clots of normal platelet-rich plasma contracting under iso-
metric conditions developed tension at an initial rate of0.1 toFIGURE 1
￿
Platelet-rich plasma clot before tension development . Platelets have changed their shape, forming short pseudopods,
and have secreted their granule contents . Fibrin strands are not oriented . Longitudinal section, uranyl acetate and lead citrate
stain . x 10,900.
FIGURE 2 Platelet-rich plasma clot contracting in the absence of an external load . Large platelet-fibrin clumps have formed,
however, no particular orientation of fibrin strands or platelets can be seen . Longitudinal section, uranyl acetate and lead citrate
stain . x 9,000 .
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FIGURE 3 Tension development in thrombin-clotted platelet-rich
plasma. Citrated platelet-rich plasma, 0 .9 ml, containing 3 .3 x 108
platelets/ml was clotted with 1 U thrombin (Parke-Davis) . The
tension recorded is expressed in g/cm z (initial cross-sectional area) .
0.2 g/min per cm' (initial cross-sectional area) (Fig. 3) . When
fixed under tension after having attained a force of 1.6 g/cm 2 ,
the isometrically contracting clots differed strikingly in ultra-
structural appearance from clots contracting in the absence of
an extrenal load (Figs . 4-7) . Longitudinal sections revealed
many long, thin fibrin strands oriented like cables in the axis
of tension . Platelet-fibrin clumps in the same sections tended
to be elongated or spindle-shaped . Long platelet bodies or
pseudopods extended in the axis of tension along similarly
oriented fibrin strands. Bundles of microtubules and microfil-
aments present in the extended platelet segments were also
oriented in the direction of force generation . The pattern of
extended platelet segments containing longitudinally arranged
microtubule or microfilament bundles in close apposition to
long fibrin cables in the axis of tension predominated in
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Platelet-rich plasma clot fixed under tension . A clot formed using platelet-rich plasma was tied at its ends and inserted
in an apparatus to allow isometric contraction and to measure tension development . It was then allowed to contract until half-
maximal tension was achieved and fixed . Pseudopods (Ps) can be seen extending out from the platelet-fibrin clumps. The section
is cut longitudinally as described in the text and shows the alignment of pseudopods and beginning alignment of fibrin strands in
the direction of tension . Longitudinal section, uranyl acetate and lead citrate stain . x 18,000 . The bidirectional arrow, where
present, indicates the direction of tension .
FIGURE 5
￿
A clot was formed using platelet-rich plasma and then allowed to undergo contraction isometrically until half-maximum
tension was achieved . Platelet pseudopods and fibrin strands can be seen aligning in the direction of tension . Longitudinal section,
uranyl acetate and lead citrate stain . x 7,800.
longitudinal sections . Cross sections of the isometrically con-
tracted clots (Fig . 8) yielded the contrasting appearance . Cables
of fibrin similar to those in longitudinal sections were virtually
absent . Portions ofplatelets in close apposition to fibrin strands
contained hollow-cored circular profiles ofmicrotubules. Plate-
let segments with longitudinally oriented bundles oftubules or
microfilaments were as rare in cross sections as they were
common in sections cut in the coronal plane.
Groups of 3 to 10 serial and adjacent longitudinal sections
were examined to determine if only pseudopods or entire
platelet bodies assumed extended configurations in isometri-
cally contracted clots (Figs. 9 and 10) . Extended portions of
the cells in close apposition to the long fibrin strands away
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from aggregates appeared most often to be single pseudopods.
However, no clear demarcation between pseudopods and plate-
let bodies could be identified in the aggregates. Therefore, the
entire platelet appears involved in establishing the longitudi-
nally oriented platelet-fibrin associations identified in clots
fixed under isometric conditions .
To further assess the role of platelets, in particular the
requirement for platelet-platelet attachment, clots were formed
using platelet-poor plasma and a concentration of platelets
varying from 0 to 4.8 x 1Ob/P,1. The rate of tension produced
was roughly proportional to the number of platelets present
(Fig . 11) . With increasing numbers of platelets, the size of the
platelet clumps increased and the distance between them de-creased . The orientation of fibrin fibers in the direction of
tension, seen under isometric conditions, occurred only when
force was generated in the presence of platelets . Clots of
platelet-poor plasma showed randomly oriented fibrin fibers
and the number of fibrin strands aligned in the direction of
tension increased as platelet numbers were increased . A section
from a clot made from plasma containing 3 x 10' platelets/I,1
is shown in Fig . 12 . Clots made from plasma containing 4 .8 x
105 platelets/[,1 were similar to those shown in Figs . 4-7 . As
platelet numbers were varied from 3 x 10'/11 of4.8 x 105/t.1,
the tension increased linearly.
Role of Fibrin Cross-linking on Isometric
Clot Contraction
When normal platelets were washed and resuspended in
factor XIII-deficient plasma, the tension developed in the
thrombin-generated clot was about tenfold diminished (Fig .
13 b) as compared to the control containing washed platelets
resuspended in normal plasma (Fig. 13 a). The clot formed in
the absence offactor XIII wasmuch softer than usual, showed
a loss of elasticity and care had to be taken when tieing the
thread or it would cut right through the clot . Tension was
restored to normal when pure factor XIII was added to the
factor XIII-deficient system before clotting with thrombin (Fig .
13 c). Platelets in factor XIII-deficient clots were in small to
medium size nonelongated clumps (Fig . 14) . The most striking
change was seen in the fibrin fibers which were randomly
oriented and formed only a few thick, striated fibers . Prepara-
tions offactor X111-deficient plasma from two different sources
were evaluated . In one, striated fibrin strands were absent and
in the other they were present, but strikingly reduced . Platelets
within these clots clumped together to some extent, but the
distance between clumps remained large . Upon restoration of
FIGURE 6
￿
A higher power view of a sample of platelet-rich plasma contracted isometrically until maximum tension was achieved .
A long platelet pseudopod with numerous microtubules (arrow) can be seen . Longitudinal section, uranyl acetate and lead citrate
stain . x 27,000 .
FIGURE 7
￿
Another view of the sample shown in Fig . 6 to show close interaction between a platelet pseudopod (Ps) and a fibrin
strand (F) . Longitudinal section, uranyl acetate and lead citrate stain . x 46,000 .
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tension . Fibrin (F) strands are cut almost exclusively in cross section as are platelet pseudopods . Microtubules (arrows) are present
within all cross sections of pseudopods . Cross section, uranyl acetate and lead citrate stain . x 50,000 .
pure factor XIII, thick fibrin strands oriented in the direction
of tension were produced and platelets developed pseudopods
(Fig . 15 a and b) which extended along the fibrin strands .
Deficient clot retraction was not restricted to isometric condi-
tions, but was also found in the absence of an external load in
the floating clot technique.
Role of Abnormal Platelets in Clot Retraction
Clots were made from platelet-rich plasma from a patient
with Glanzmann's thrombasthenia . Ultrastructurally, these
clots did not show an orientation of the fibrin strands in the
direction of isometric tension (Fig. 16) and the platelets did
not form clumps .
Clots were alsomade from platelet-rich plasma from patients
with either absent dense bodies or markedly decreased alpha
granules . In both cases, clots formed normally, had a normal
ultrastructural appearance, and generated tension normally .
Effects of Inhibitors
Addition of prostaglandin EL (2.8 x 10-6 M) with theophyl-
line (2 x 10-3 M),EGTA (10-2 M), cytochalasin B (4 x 10-5
M), or vincristine (10-4 M) before clot formation, prevented
the generation oftension and the development ofplatelet-fibrin
clumps .
When EGTA (10-2 M, not shown), cytochalasin B (4 x 10-5
M), or vincristine (10-4 M) were added at half-maximal tension,
they all produced relaxation (Fig . 17) . Whereas the tension
returned to the baseline in the presence of EGTA, it was
reduced to about 70 and 50% respectively, in the presence of
cytochalasin B and vincristine at the concentrations used . Full
tension was restored upon washing the EGTA and cytochalasin
Ill-treated clot with Tyrode buffer . Lower concentrations of
vincristine were ineffective . Whereas 4 x 10-6M cytochalasin
B did not cause relaxation but prevented tension to develop
further, relaxation produced by4 x 10-6M cytochalasinE was
similar to that caused by a tenfold concentrated cytochalasin
B (Fig. 17) . Associated with the decrease in tension produced
by EGTA, aggregates of fibrin and platelets within the clot
became more loosely organized and orientation of fibrin
strands was lost (Fig . 18) . When cytochalasin B was added at
half-maximal tension, the platelet-fibrin clumps persisted,
though the platelets within the clumps became less tightly
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packed (Fig . 19) . Fibrin strands remained largely oriented in
the direction of tension, but platelet bodies and pseudopods at
the edge of a clump became more rounded in appearance .
These changes were associated with disappearance oforiented
bundles of microfilaments in the platelet cytoplasm, and their
replacement by a granular appearance, as described earlier
(41) . When vincristine was added at half-maximal tension, the
relaxation was associated with the loss ofplatelet microtubules
and an apparent decrease of the pseudopod length (Figs. 20
and 21) . The fibrin fibers remained oriented in the direction of
isometric tension.
DISCUSSION
The results of the present study can best be evaluated in the
light of earlier studies and models of clot contraction (Fig. 22) .
The essential importance ofplatelets as the actively contracting
or force-generating component necessary for contraction was
well documented in the studies of Budtz-Olsen (5) . Noteworthy
also was the observation by Sokal (39) ofpseudopods emerging
radially and over a considerable distance from platelet masses
and attaching to fibrin fibers. The role of fibrin in clot con-
traction has been less clear. One concept has been that fibrin
serves primarily as a load to be collected or gathered together
by the platelets. Development of this concept produced the
zipper model of clot contraction (9), according to which plate-
lets extend pseudopods until they come into contact . This is
followed by a "zippering" together of the membranes of adja-
cent platelets to contract the clot (Model 1). Fibrin would be
gathered and compacted into the space between platelet mem-
branes but would not provide an essential structural compo-
nent, except as a mesh for platelets to extend pseudopods and
contact other platelets. Support for the idea that fibrin serves
primarily as a load to be compressed by platelets carne from
studies with clots prepared from factor XIII-deficient plasma .
These studies appeared to show little change in the contraction
of clots made from non-cross-linked fibrin compared to clots
formed from normal fibrin (36) . One study in which cross-
linking appeared to delay retraction was used as further support
for the fibrin = load concept (32) .
The methods used to assess clot retraction in these earlier
studies could have led to artifactual results, and it was essential
to reassesses the role of factor XIII . In our studies, underFIGURES 9 and 10
￿
Adjacent serial sections in the longitudinal plane through the same platelet . The body and pseudopods extend
in the axis of tension . Microtubules (T) are prominent in one pseudopod and masses of microfilaments (MF) in the opposite
extension in Fig . 9 . The microfilaments are replaced by microtubules (T) in a deeper section of the same pseudopod in Fig . 10 .
Longitudinal sections, uranyl acetate and lead citrate stain . Fig . 9, x 30,500; Fig . 10, x 30,000 .
"
110
￿
0
￿
conditions of isometric contraction, cross-linking of fibrin was
100
￿
quite clearly critical . Factor XIII deficient clots failed to de-
velop tension and this could be corrected by addition of pure
0
￿
0
￿
factor XIII . Cross-linking of fibrin may function either to
70
￿
provide an improved support for the extension of platelet
É 60
￿
, '
￿
pseudopods or to provide fibrin with high enough tensile
50
￿
strength so that it does not fall apartwhen subjected to tension
C, 40
￿
by platelets .
30
￿
Another approach for evaluating the relative role ofplatelets
and fibrin was to vary the platelet concentration . If platelet
'°
￿
platelet interaction was the important component for force
0
￿
30 60 90 120 150 180210 240270300330 360390 420450 480 510540
￿
generation, as suggested by Model 1, small platelet numbers
PL,ATELET COUNT , . ,03 No
￿
should be much less able to make pseudopod-pseudopod con-
FIGURE 11
￿
Variation in the rate of tension development in a plasma
￿
tact . Tension should fall off exponentially with a decrease in
clot with increasing concentrations of washed platelets .
￿
platelet numbers, unless the platelets had some way of com-
COHEN, GERRARD, AND WHITE
￿
Isometric Clot Contraction
￿
781FIGURE 12
￿
Clot formed using a low concentration of washed plate-
lets suspended in homologous platelet-poor plasma (3 X 104 plate-
lets/,ul) and allowed to contract isometrically . Some alignment of
platelets and fibrin is apparent but less than at higher platelet
concentration . Longitudinal section, uranyl acetate and lead citrate
stain . X 2,000.
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FIGURE 13
￿
The role of factor XIII in tension development . Washed
platelets were resuspended at a final concentration of 5.5 X 108
platelets/ml in normal plasma (a), in factor X111-deficient plasma
(b), or in factor X111-deficient plasma supplemented with 24 fig pure
factor X111/ml (c) . Factor X111-deficient plasmas from two other
patients gave the same result . Clots a and c were insoluble in 5 M
urea or 1°% monochloracetic acid whereas, clot b was soluble under
the same conditions .
pensating by extending longer pseudopods . If platelet-fibrin
interaction was the crucial factor for the generation of force, as
suggested by other models (Fig . 22), tension development
should fall off linearly with a decrease in platelet concentration.
We found that the rate of tension development decreased
linearly with a decrease in platelet concentration . The obser-
vation argues strongly for the importance of platelet-fibrin
interaction, rather than platelet-platelet interaction in force
generation .
Ultrastructural studies ofclots prepared at low platelet con-
centrations revealed some alignment of fibrin strands but less
than at high platelet concentrations . Pseudopods appeared
shorter, rather than longer, when low numbers ofplatelets were
used to form the clots . It is possible that long pseudopods not
in the plane of section were missed. However, the presence of
some aligned pseudopods should have meant the visibility of
at least a few very long pseudopods if these had been present.
None were seen . Therefore, it is unlikely that the platelets were
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able to compensate for decreased numbers by extending longer
pseudopods. These findings provide support for the concept
that platelet-fibrin interaction, rather than platelet-platelet in-
teraction is responsible for generation oftension in contracting
clots and Model 1 should be rejected .
A further evaluation ofthe role of platelet-fibrin interaction
was done using platelets from a patient with thrombasthenia .
These platelets lack glycoproteins Ilb and III and lack fibrin-
ogen receptors (2, 30). There is no firm evidence that the
platelet-fibrin bond is identical to the platelet-fibrinogen at-
tachment . However, this seems likely. Clots prepared using
thrombasthenic platelets failed to generate tension or align
fibrin or pseudopods. This is consistent with the critical role of
platelet-fibrin interaction in this process . In contrast to the
defective clot retraction in thrombasthenia, congenitally ab-
normal platelets with deficient dense bodies or alpha granules
showed normal clot contraction, suggesting that granule con-
tents or secretion are not essential.
We next considered the two models for clot contraction
involving platelet-fibrin interaction, The waving pseudopod
model (8), Model 2 (Fig . 22), would predict many pseudopods
oriented opposite to the direction of tension . Longitudinal
sections of clots fixed during isometric contraction, however,
revealed little evidence to support this hypothesis . Platelet-
fibrin clumps, platelet bodies and pseudopods were aligned in
the axis of tension, and pseudopods arranged across the lon-
gitudinal axis were rarely observed . Therefore, Model 2 should
be rejected .
Model3 (Fig. 22) in which platelet pseudopods pull in fibrin
strands (35) was more consistent with our findings, but needed
some revision . We found that long pseudopods and extended
platelet bodies, aligned along fibrin strands, were still present
under conditions of maximal tension, suggesting that pseudo-
pod extension and retraction was a continuous process rather
thanjust one extension and retraction as earlier envisaged. The
FIGURE 14
￿
A clot was formed using washed platelets suspended in
factor X111-deficient plasma (7 X 105 platelets/pl) and allowed to
contract isometrically . Platelet-fibrin clumps form as shown, but
these consist primarily of platelets and the fibrin is present only in
short scattered segments . No orientation or alignment of platelets
or fibrin is seen . Longitudinal section, uranyl acetate and lead citrate
stain . X 8,000.FIGURE 15
￿
A clot was formed using washed platelets (7 X 105/fll), suspended in factor X111-deficient plasma to which was added
24 gg/ml purified factor XIII . The clot formed after thrombin addition (1 U/ml) was allowed to contract isometrically . Long fibrin
strands formed and platelet pseudopods and fibrin strands aligned in the direction of tension as shown . Longitudinal sections,
uranyl acetate and lead citrate stain . a, X 8,000; b, X 36,000 .
FIGURE 16 A clot was formed using a sample of platelet-rich plasma from a patient with Glanzmann's thrombasthenia and
allowed to contract isometrically . No tension was produced . Platelets remained single and did not form platelet-fibrin clumps . No
alignment of platelet pseudopods or fibrin strands in the direction of tension was seen . Longitudinal section, uranyl acetate and
lead citrate stain . X 3,750.
tips of pseudopods were often less closely attached to the fibrin
than regions near the base . This finding suggested the possi-
bility that the membrane at the tip may continue to flow and
extend outward even as the portions near the base are being
pulled inward by contractile microfilaments .
Studies with the inhibitors, vincristine and cytochalasin B,
suggested that microtubules and microfdaments are important
for isometric contraction of clots . Earlier investigations dem-
onstrated that concentrations of vincristine lower than those
used in the present study will dissolve platelet microtubules
without inhibiting clot retraction (44) . However, the same low
doses of colchicine and vinca alkaloids which are ineffective in
platelet-rich plasma will inhibit clot retraction in diluted sam-
ples of platelet-rich plasma (7) . Similar differences in amounts
of the mitosis inhibitor required to inhibit platelet secretion
compared to minimum concentrations necessary to remove
microtubules have been noted in other studies (28, 37, 38) .
As similar dichotomy exists with regard to effective concen-
trations of cytochalasins B and E . Concentrations similar to
those used in the present study can inhibit total polymerization
of actin in platelets (15) . These amounts, necessary to block
clot retraction or cause relaxation, do not appear toxic to other
cell functions (23, 41) . Removal of cytochalasin B by washing
the clot several times restores normal contractile activity and
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FIGURE 17
￿
The influence of cytochalasin B and vincristine on ten-
sion development . The experimental conditions were the same as
in Fig . 3, except that the bath was drained and cytochalasin B (20
hg/ml) or vincristine (100 pM) in Tyrode buffer were added as
shown . No effect was seen when ethanol, the cytochalasin solvent,
was added at 0.5% concentration in Tyrode buffer.
FIGURE 18 A clot formed using platelet-rich plasma was allowed
to contract isometrically to reach half-maximal tension at which
point the bath was drained and then 10 mM EGTA in Tyrode buffer
was added . The clot relaxed until no remaining tension was mea-
sureable and was then fixed for study . Platelets continued to be
associated in small platelet-fibrin clumps, however, the association
of platelets and fibrin was loose . Fibrin strands and platelet pseu-
dopods were no longer aligned longitudinally within the clot . Lon-
gitudinal section, uranyl acetate and lead citrate stain . x 13,000.
full isometric tension. Concentrations ofcytochalasin B similar
to those used in the present study were also required to fully
inhibit several functional activities of monocytes (45). Thus,
the higher concentrations of vincristine and cytochalasin B
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required in the present study to influence clot retraction com-
pared to amounts needed to disassemble microtubules or pre-
vent actin polymerization in vitro may not be cytotoxic and
consistent with concentrations used to inhibit othercell systems .
It is possible that preservation offibrin orientation and platelet-
fibrin interactions in clots treated with vincristine or cytochal-
asin B may result in significant residual tension . Higher con-
centrations of the two agents to produce maximal relaxation of
individual platelets may be necessary under these conditions
to cause significant changes in isometric tension .
Pseudopod and platelet body lengths appeared decreased in
clots to which vincristine or cytochalasin B had been added at
half maximal tension, despite persistence of the alignment of
fibrin strands. The observed changes in pseudopod length and
rounding-up of platelet extensions under these conditions were
unlikely to represent artefacts due to the plane of section, since
fibrin strands remained oriented in the longitudinal axis . It is
probable that microtubules are important in the process of
extension and stabilization of pseudopods and platelet bodies
along fibrin strands in the axis of tension. By acting as a
cytoskeletal support system the microtubules may facilitate
contraction by oriented bundles of microfilaments .
The loss of fibrin orientation associated with total loss of
tension upon addition of EGTA suggests a crucial role of
calcium in platelet-fibrin interaction by analogy to platelet-
fibrinogen interaction (27). EGTA may act through dissocia-
FIGURE 19 A clot formed using platelet-rich plasma was allowed
to contract isometrically to reach half-maximal tension at which
point the bath was drained and then 4 x 10-5 M cytochalasin B in
Tyrode buffer was added . The clot relaxed as shown in Fig . 17 and
was then fixed for study . Platelets are in loose clumps and are
rounded with a noticeable absence of long pseudopods . Fibrin
orientation in the direction of tension is maintained . Microtubules
(arrows) are still present within the platelets . Longitudinal section,
uranyl acetate and lead citrate stain . x 13,000.FIGURES 20 and 21
￿
A clot formed using platelet-rich plasma was
allowed to contract isometrically to reach half-maximal tension at
which point the bath was drained and then 10-" M vincristine in
Tyrode buffer was added . The clot relaxed as shown in Fig. 17 and
was then fixed for study. Platelets and fibrin are in relatively loose
clumps. In Fig . 20 platelets have lost their long pseudopods and are
relatively rounded in appearance, although orientation of the fibrin
strands in the direction of tension is maintained . At higher magni-
fication in Fig . 21, platelets have lost their microtubules and instead
show crystalloid inclusions (arrow) typical of vincristine-treated
platelets . Longitudinal section, uranyl acetate and lead citrate stain .
20, X 7,500 ; 21, X 23,000 .
tion of the bonds between platelets and fibrin . Alternatively,
the thrombin-activated platelets within a clot may undergo
membrane alterations associated with ATP degradation (21)
and causing leakage ofcalcium . This cation is then trappedby
EGTA added externally, preventing, therefore, intracellular
contractile protein interactions required for tension develop-
ment . Since cytochalasin B influences the platelet contractile
mechanism through depolymerization of actin filaments (4)
without affecting the platelet-fibrin relationships, it is likely
that EGTA influences both contraction and the interaction of
platelets with fibrin .
The findings of the present study, taken in the context of
present knowledge of platelet contractile proteins, suggest that
the process may take place as shown in Fig . 23 . The main
features of this model involve the development of a platelet
contractile activity and of platelet-fibrin interaction. In this
concept platelets activated by thrombin initially undergo po-
lymerization of actin (31, 34), change their shape, extend
pseudopods, and have fibrinogen binding sites generated on
their surfaces . The polymerization of fibrin thus enables plate-
let-fibrin attachments to develop provided external calcium is
present . With the formation of long fibrin strands, platelet
pseudopods now have a structure alongwhich they can spread
or crawl . We suggest that fibrin strands cross-linked in the
presence of factor XIII form such a surface structure for
extension of pseudopods. External attachment of fibrin may
enhance internal actin polymerization. Orientation of pseudo-
pods may be dependent on such polymerization associated
with the reorganization and extension of microtubules . Con-
currently with pseudopod extension, polymerized actin in the
pseudopod base may begin to interact with myosin in the cell
center initiating retraction . The gradual pulling of pseudopods
bound to fibrin,perhaps even as they continue to extend at the
tips, provides a mechanism for the platelet to gather in fibrin
strands so that strands remaining outsidethe developing plate-
let-fibrin clumps become stretchedand aligned in the direction
of tension (Fig. 24) . The process thus achieves the pictureseen
at maximal tension of large platelet-fibrin clumps with tightly
stretched fibrin strands in between .
MODEL I
￿
MODEL 2
￿
MODEL 3
ZIPPER MODEL
￿
WAVING
￿
RETRACTION OF
PSEUDOPOD MODEL
￿
PSEUDOPODS
TO PULL IN FIBRIN
FIGURE 22
￿
Earlier models of clot contraction . Heavy lines represent
fibrin fibers ; light lines delineate platelets .
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￿
A proposed model for the interaction of platelets and
fibrin in an isometrically contracting clot . The platelet initially forms
attachments to fibrin strands (a) . Pseudopods then start to crawl
along the fibrin strands (b) . We speculate that such pseudopod
extension may involve the interaction of actin with actin binding
protein and microtubules . In addition, we speculate that actin-
myosin interaction within the body of the platelet (b, c, d) is
responsible for drawing fibrin strands attached on opposite sides of
platelet closer together . Compaction of a fibrin strand in association
with the platelet is beginning in d . As more fibrin strands are
compacted within such platelet-fibrin aggregates, the strands that
remain outside such aggregates are pulled to create the tension
measured and to align them in the direction of tension as shown in
Fig . 24 .
FIGURE 24
￿
Alignment of fibrin strands during tension development
as it would occur postulating the model of clot retraction shown in
Fig . 23 .
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